Literature DB >> 22196503

Effects of manual acupuncture at GB34 on carbon tetrachloride-induced acute liver injury in rats.

Nobuyuki Tanahashi1, Juri Shikami, Misao Yoneda, Torao Ishida.   

Abstract

Manual acupuncture at Yanglingquan (GB34) is reported to have a beneficial effect on chronic liver damage. We, therefore, studied the effect of manual acupuncture at GB34 on acute liver damage. Rats were administered carbon tetrachloride (CCl(4)) or olive oil, and direct manual acupuncture was subsequently performed at GB34 or at a sham point (a nonacupoint). In rats administered with CCl(4), the serum levels of aspartate aminotransferase and alanine aminotransferase, the total cholesterol concentration, and the levels of hepatic thiobarbituric-acid-reactive substances were suppressed by acupuncture at GB34 when compared with acupuncture at the sham point. By contrast, there was little histological difference in the liver between acupuncture at GB34 and that at the sham point in rats administered with CCl(4). These results suggest that manual acupuncture at GB34 tends to improve acute liver damage but is not sufficient by itself to completely resolve the hepatic injury.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22196503     DOI: 10.1016/j.jams.2011.09.012

Source DB:  PubMed          Journal:  J Acupunct Meridian Stud        ISSN: 2005-2901


  2 in total

1.  Photoacoustic imaging of cerebral hypoperfusion during acupuncture.

Authors:  B Z Chen; J G Yang; D Wu; D W Zeng; Y Yi; N Yang; H B Jiang
Journal:  Biomed Opt Express       Date:  2015-08-05       Impact factor: 3.732

2.  Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.

Authors:  Min Jung Lee; Minhee Jang; Jonghee Choi; Gihyun Lee; Hyun Jung Min; Won-Seok Chung; Jong-In Kim; Youngheun Jee; Younbyoung Chae; Sung-Hoon Kim; Sung Joong Lee; Ik-Hyun Cho
Journal:  Mol Neurobiol       Date:  2015-01-13       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.